Dr. Chang’s published reports and presentations on cancer therapies: 2004 – 2020
Systemic treatment with anti-PD-1 antibody nivolumab in combination with vaccine therapy in advanced pancreatic cancer. J Clin Oncol 34, 2016 (suppl; abstr 3092).
Chinese herbal medicine and fluorouracil-based chemotherapy for colorectal cancer: A quality-adjusted meta-analysis of randomized controlled trials. Integr Cancer Ther. 2016 Sep; 15(3):285-307.
Dendritic cells generated with anti-PDL1 checkpoint blockade for treatment of advanced pancreatic cancer. J Clin Oncol 33, 2015 (suppl; abstr 4128).
Gamme-delta T cells in combination with Newcastle Disease virus and Dendritic Cell therapy as a novel immunotherapeutic approach in treating non-small cell lung cancer. J Clin Oncol 32:5s, 2014 (suppl; abstr 3062) NfP2X7, a novel target for immune therapeutic approaches in cancer treatment. J. Clin Oncol 31, 2013 (suppl; anstr 3094)
Discovery of anticancer drugs from antimalarial natural products. Drug Discovery Today. 2012 Sep; 17 (17-18): 942-53.
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus. In: Journal of Clinical Oncology, 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 29, No 15_suppl (May 20 Supplement), 2011: 2508
Immunotherapy with dendritic cells as a second-line therapy in advanced pleural mesothelioma. In: Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 28, No 15_suppl (May 20 Supplement), 2010: e13063
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. In: Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (May 20 Supplement), 2009: 3028
Immunotherapy with dendritic cells primed with an allogenic melanoma cell line in advanced metastatic melanoma. In: Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition. Vol 26, No 15S (May 20 Supplement), 2008: 20026.
Dendritic Cell Therapy in Glioblastoma Multiforme. In: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007:3065.
Cancer therapy with tumor cell lysate pulsed monocyte-derived dendritic cells in patients with metastastic colon cancer: Improvement by danger signals. In: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 2563.
Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer. In: Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005: 2528.
Cancer therapy with unloaded monocyte-derived dendritic cells in patients with inoperable pancreatic and gall bladder cancer. In: Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 2569
